N

Neumora Therapeutics Inc
NASDAQ:NMRA

Watchlist Manager
Neumora Therapeutics Inc
NASDAQ:NMRA
Watchlist
Price: 1.78 USD Market Closed
Market Cap: 293.3m USD

Wall Street
Price Targets

NMRA Price Targets Summary
Neumora Therapeutics Inc

Wall Street analysts forecast NMRA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NMRA is 9.35 USD with a low forecast of 3.03 USD and a high forecast of 18.9 USD.

Lowest
Price Target
3.03 USD
70% Upside
Average
Price Target
9.35 USD
425% Upside
Highest
Price Target
18.9 USD
962% Upside
Neumora Therapeutics Inc Competitors:
Price Targets
ZYDUSLIFE
Zydus Lifesciences Ltd
15% Upside
249420
Il Dong Pharmaceutical Co Ltd
22% Upside
CRMD
CorMedix Inc
50% Upside
4516
Nippon Shinyaku Co Ltd
2% Upside
ACUTAAS
Acutaas Chemicals Ltd
13% Upside
IMP
Imexpharm Corp
5% Upside
600380
Joincare Pharmaceutical Group Industry Co Ltd
37% Upside
512
Grand Pharmaceutical Group Ltd
51% Upside

Revenue
Forecast

Revenue Estimate
Neumora Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Neumora Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Neumora Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NMRA's stock price target?
Price Target
9.35 USD

According to Wall Street analysts, the average 1-year price target for NMRA is 9.35 USD with a low forecast of 3.03 USD and a high forecast of 18.9 USD.

Back to Top